Delivering Value To Those We Serve

Overview

Recent News

Date Title and Summary
Toggle Summary Assertio Therapeutics Announces Closing of Sale of NUCYNTA® Franchise to Collegium Pharmaceutical for $375.0 Million
Also Announces its Senior Secured Debt Has Been Repaid in Full LAKE FOREST, Ill. , Feb. 13, 2020 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (“Assertio” or “The Company”) (NASDAQ: ASRT), today announced the closing of its previously disclosed definitive agreement (“Agreement”) with Collegium
Toggle Summary Assertio Therapeutics Announces Sale of NUCYNTA® Franchise to Collegium Pharmaceutical for $375.0 Million
Company Intends to Use Cash Proceeds to Retire its Outstanding Debt Company Intends to Use Improved Balance Sheet to Pursue Business Development, Strategic Partnerships and Investment Opportunities LAKE FOREST, Ill. , Feb. 06, 2020 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc.
Toggle Summary Assertio Therapeutics Announces Closing of Gralise® Sale to Alvogen and Expects Full-Year 2019 Neurology Franchise Net Sales Above Upper End of Prior Guidance
LAKE FOREST, Ill. , Jan. 13, 2020 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (“Assertio” or “The Company”) (NASDAQ: ASRT), today announced the closing of its previously disclosed agreement (“Agreement”) with Alvogen , a global privately held pharmaceutical company, under which Alvogen will

Upcoming Events

There are currently no events to display.

Recent SEC Filings

Filing date Description Form Filing Group View

An amendment to the SC 13G filing

SC 13G/A
3,4,5
View HTML

An amendment to the SC 13G filing

SC 13G/A
3,4,5
View HTML

An amendment to the SC 13G filing

SC 13G/A
3,4,5
View HTML

A statement of beneficial ownership of common stock by certain persons

SC 13G
3,4,5
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
View HTML

IR Contact

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: 800.509.5586
http://www.continentalstock.com
 

Independent Registered Public Accounting Firm

Ernst & Young LLP
Palo Alto, CA
 

Investor Relations Contact

investor@assertiotx.com